The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
Subject to completion dated July 14, 2026
Pricing supplement
To prospectus dated April 17, 2026,
prospectus supplement dated April 17, 2026 and
product supplement no. 1-I dated... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of July 2026
Commission File Number 001-39354
Quhuo Limited
3F, Building A, Xin’anmen, No. 1 South Bank
Huihe South Street, Chaoyang District Beijing,
People’s Republic of China
+86 (10) 5923-6208
(Address of principal... (continue reading...)
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THESECURITIES EXCHANGE ACT OF 1934
For the month of July 2026
Commission File Number 001-41836
Birkenstock Holding plc
(Translation of registrant’s name into English)
1-2 Berkeley Square
London W1J 6EA
United Kingdom(Address of principal executive office)
Indicate by check mark whether the registrant files or will... (continue reading...)
Filed Pursuant to Rule 424(b)(2)Registration No. 333-285537
The information in this prospectus supplement is not complete and may be changed. This prospectus supplement and the accompanying prospectus are not an offer to sell these securities and are not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
SUBJECT TO COMPLETION, DATED JULY 15, 2026
Prospectus Supplement
(To... (continue reading...)
More SEC Filings
View Older Stories-
Form 424B2 JPMORGAN CHASE & CO
-
Form 8-K Genasys Inc. For: Jul 13
-
Form 6-K POMDOCTOR Ltd For: Jul 15
-
Form SCHEDULE 13D/A RAYONIER ADVANCED MATERI Filed by: AIPCF VIII (Cayman), Ltd.
-
Form ATS-N/UA BLUE OCEAN ATS, LLC
-
Form NT 10-Q Ankam, Inc. For: May 31
-
Form 6-K Glass House Brands Inc. For: Jul 15
-
Form SCHEDULE 13G SCANSOURCE, INC. Filed by: PZENA INVESTMENT MANAGEMENT LLC
-
Form 8-K Profound Medical Corp. For: Jul 15
-
Form SUPPL Glass House Brands Inc.
-
Form NT 10-Q Hestia Insight Inc. For: May 31
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form D DataBahn, Inc. \DE
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form 13F-HR Swedbank AB For: Jun 30
-
Form 8-K MORGAN STANLEY For: Jul 15
-
Form 424B2 CITIGROUP INC
-
Form 8-K JOHNSON & JOHNSON For: Jul 15
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 4 TORO CO For: Jul 13 Filed by: Totsky Joanna M.
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 8-K CONAGRA BRANDS INC. For: Jul 15
-
Form DEFA14A Senti Biosciences Holdin
-
Form 8-K Senti Biosciences Holdin For: Jul 14
-
Form 424B2 CITIGROUP INC
-
Form 6-K Legend Biotech Corp For: Jul 15
-
Form 10-Q Perceptive Capital Solut For: Jun 30
-
Form 10-D WFN CREDIT CO LLC For: Jun 30
-
Form 8-K Worthington Steel, Inc. For: Jul 15
-
Form 10-D Synchrony Card Funding, For: Jun 30
-
Form 6-K GENMAB A/S For: Jul 15
-
Form 497K ETFis Series Trust I
-
Form 497 ETFis Series Trust I
-
Form 4 GDS Holdings Ltd For: Jul 15 Filed by: KING JONATHAN ALLEN
-
Form D Socomy PTE LTD
-
Form 8-K ENTEGRIS INC For: Jul 15
-
Form 6-K Freightos Ltd For: Jul 15
-
Form D Mainsheet Capital Partne
-
Form 4 GDS Holdings Ltd For: Jul 15 Filed by: Zhang David
-
Form 4 GDS Holdings Ltd For: Jul 15 Filed by: BAHARUDIN ZULKIFLI BIN
-
Form 4 New Oriental Education For: Jul 15 Filed by: Hsieh Louis
-
Form 8-K HYCROFT MINING HOLDING For: Jul 09
-
Form 8-K Axsome Therapeutics, For: Jul 15

